Revision of Prior Period Financial Statements (Details) - Schedule of unaudited interim condensed financial statements - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Dec. 23, 2020
Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock subject to possible redemption	$ 134,522,628	$ 134,983,359	$ 135,094,307
Common stock	485	480	479
Additional paid-in capital	5,004,871	5,118,821	5,007,859
Balance Sheet at December 31, 2020
Accumulated deficit	$ (5,345)	$ (119,298)
Statement of Operations for the year ended December 31, 2020
Basic and diluted weighted average shares outstanding, common stock subject to redemption (in Shares)
Basic and diluted weighted average shares outstanding, common stock not subject to redemption
Basic and diluted weighted average shares outstanding, common stock not subject to redemption (in Shares)
Basic and diluted weighted average shares outstanding, common stock (in Shares)	18,169,000	4,198,081
Statement of Cash Flows for the year ended December 31, 2020
Initial value of common stock subject to possible redemption		$ 135,094,307
Change in value of common stock subject to possible redemption	$ 120,140	(110,948)
Reclassification of offering costs related to public shares
Subsequent measurement of common stock subject to redemption
Subsequent measurement of common stock subject to redemption (interest earned on trust account)
Revision of Prior Period, Adjustment [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock subject to possible redemption	4,884,666	4,399,888	4,285,693
Common stock	(48)	(43)	(42)
Additional paid-in capital	(4,884,618)	(4,974,521)	(4,860,327)
Balance Sheet at December 31, 2020
Accumulated deficit	$ 0	$ (6,184)
Statement of Operations for the year ended December 31, 2020
Basic and diluted weighted average shares outstanding, common stock subject to redemption (in Shares)	13,800,000	339,344
Basic and diluted weighted average shares outstanding, common stock not subject to redemption	$ 4,369,000
Basic and diluted weighted average shares outstanding, common stock not subject to redemption (in Shares)		3,429,593
Basic and diluted weighted average shares outstanding, common stock (in Shares)	0	(429,144)
Statement of Cash Flows for the year ended December 31, 2020
Initial value of common stock subject to possible redemption		$ (11,621,066)
Change in value of common stock subject to possible redemption	$ (120,140)	110,948
Reclassification of offering costs related to public shares		(2,946,021)
Subsequent measurement of common stock subject to redemption		18,852,780
Subsequent measurement of common stock subject to redemption (interest earned on trust account)	24,047	3,247
As Adjusted [Member]
Condensed Financial Statements, Captions [Line Items]
Common stock subject to possible redemption	139,407,294	139,383,247	139,380,000
Common stock	437	437	437
Additional paid-in capital	120,253	144,300	$ 147,532
Balance Sheet at December 31, 2020
Accumulated deficit	$ (5,345)	$ (125,482)
Statement of Operations for the year ended December 31, 2020
Basic and diluted weighted average shares outstanding, common stock subject to redemption (in Shares)	13,800,000	339,344
Basic and diluted weighted average shares outstanding, common stock not subject to redemption	$ 4,369,000
Basic and diluted weighted average shares outstanding, common stock not subject to redemption (in Shares)		3,429,593
Basic and diluted weighted average shares outstanding, common stock (in Shares)	18,169,000	3,768,937
Statement of Cash Flows for the year ended December 31, 2020
Initial value of common stock subject to possible redemption		$ 123,473,241
Change in value of common stock subject to possible redemption
Reclassification of offering costs related to public shares		(2,946,021)
Subsequent measurement of common stock subject to redemption		18,852,780
Subsequent measurement of common stock subject to redemption (interest earned on trust account)	$ 24,047	$ 3,247